Figure 1.
Outcome occurrence rate ratios and 95% confidence intervals for the association between the risk of serious bleeding and concomitant use of sulfonylureas or metformin in warfarin users
Serious bleeding: a composite outcome of gastrointestinal bleeding and non-traumatic intracranial hemorrhage